NCT05891600View on ClinicalTrials.gov

A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions

Rheumatoid Arthritis

Interventions

DEVICE

Smartclic

The SmartClic® autoinjector is a reusable, electromechanical, and single-patient device for the administration of subcutaneously administered biologics.

Trial Locations (1)

110231

Biomab Ips S.A.S., Bogotá